Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 3 7Phase NA 5Phase 4 5Phase 1 5Phase EARLY_PHASE1 4Phase 2/3 2Phase 1/2 2

Status

Recruiting 3Withdrawn 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 3Breast 3Lymphoid 2Gynecologic 2Other hematologic neoplasm 1Myeloid 1Gastrointestinal 1CNS 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Ovarian Neoplasms 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neurologic Manifestations 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Graft vs Host Disease 1Colonic Neoplasms 1Carcinoma, Renal Cell 1COVID-19 1Brain Neoplasms 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Atorvastatin × Clear all
NCT03819101 2026-05-06

PEACE-4

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting
1,210 enrolled
Genitourinary

Prostatic Neoplasms

NCT05796973 2025-06-27

MOVES

Tampere University Hospital

Phase 3 Recruiting
240 enrolled
BreastGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT04904536 2025-04-10

STRONGER

The George Institute

Phase 3 Active not recruiting
190 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

NCT04026230 2022-10-21

ESTO2

Tampere University Hospital

Phase 3 Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

NCT02201381 2022-07-18

METRICS

Health Clinics Limited

Phase 3 Withdrawn
BreastCNSGastrointestinalGynecologic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Loyola University

Phase 3 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Aarhus University Hospital

Phase 3 Recruiting
3,360 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡